1. Home
  2. |Insights
  3. |Fourth Circuit Extends Time For Retaliation Claims

Fourth Circuit Extends Time For Retaliation Claims

Client Alert | 1 min read | 05.10.04

In US ex rel Wilson v. Graham County Soil & Water Conserv. Dist. (4th Cir. April 29, 2004) (a 2-1 decision perhaps inviting en banc review) the 4th Circuit joined the 7th Circuit in holding that the 6-year statute of limitations contained in the False Claims Act also applies to retaliation claims brought under § 3730(h), even though the 6 years commences with the submission of a false claim, which, of course, necessarily precedes any act of retaliation. The majority rejected the 9th Circuit interpretation that limits the FCA limitation period to the substantive causes of action under § 3729 and for retaliation claims looks to the statute of limitations applicable to the most analogous state cause of action which, in this case, would have been North Carolina's 3 year period applicable to wrongful discharge.

Contacts

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights